MedTrace Logo

Knowledge Assessment of Women About Pictograms Associated With the Danger of Medicines Taken During Pregnancy

NCT04020432 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 281

Last updated 2023-03-22

No results posted yet for this study

Summary

Women's awareness about the danger of certain medicines taken during pregnancy presents a real public health issue. To enhance awareness and information for women and healthcare professionals, new pictograms " pregnant women " appeared on medication boxes, on October 16, 2017. These new pictograms can change women's perception of self-medication during pregnancy and of the danger of taking certain medicines for the unborn development. Furthermore, the investigators can wonder if the meaning of these pictograms is well understood. Therefore, the study's primary aim is to assess the knowledge of pregnant or childbearing age women about the pictograms associated with the danger of certain medicines taken during pregnancy.

Conditions

  • Knowledge, Attitudes, Practice
  • Pregnancy Related

Interventions

BEHAVIORAL

questionary

A quantitative questionnaire has been created under primary and secondary assumptions. Questionnaires are going to be distributed to women who are agree to participate to this study. The questionnaires are going to be delivered by the investigators. Women can answer the questionnaire in the waiting room of consultation's services. The questionnaire will be anonymous and the return of questionnaires will be made personally.

Sponsors & Collaborators

  • Centre Hospitalier HIRSON

    collaborator UNKNOWN

  • Centre Hospitalier Universitaire, Amiens

    lead OTHER

Principal Investigators

  • Alice Rousseaux · CH Hirson

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-07-11
Primary Completion
2019-12-11
Completion
2021-12-11

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04020432 on ClinicalTrials.gov